Abiraterone acetate base comprehensive for treatment of oligometastatic hormone-sensitive prostate cancer: a case report and literature review

Jian CAO; Gongqian ZENG; Shusuan JIANG; Yu XIE; Weiqing HAN

Abiraterone acetate base comprehensive for treatment of oligometastatic hormone-sensitive prostate cancer: a case report and literature review / 中华泌尿外科杂志

Jian CAO; Gongqian ZENG; Shusuan JIANG; Yu XIE; Weiqing HAN.

Chinese Journal of Urology ; (12): 39-42, 2021.

Article em Zh | WPRIM | ID: wpr-911172

Biblioteca responsável: WPRO

ABSTRACT

ABSTRACT

Conclusion:Patients with OlimHSPC who are not sensitive to traditional CAB treatment, ADT combined with abiraterone acetate neoadjuvant therapy and postoperative adjuvant therapy can be attempted.

Palavras-chave

Prostate cancer; Oligometastatic; Hormone-sensitive; Androgen deprivation therapy; Abiraterone acetate; Palliative transurethral resection of the prostate

Texto completo

Adicionar na Minha BVS

Imprimir

XML

Buscar no Google

Texto completo: 1 Base de dados: WPRIM Tipo de estudo: Diagnostic_studies Idioma: Zh Revista: Chinese Journal of Urology Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

Buscar no Google